<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Richard DiVenuto - Biotech Industry Advisor with Finance Background by Richard DiVenuto</title>
      <link>https://padlet.com/RichardDiVenuto/About</link>
      <description>Previously a wealth director at one of the country’s largest investment banks, Richard DiVenuto has over 25 years’ experience in corporate finance. Currently an entrepreneur-advisor working with businesses across the country, he leverages his experience to grow startups. Richard DiVenuto has advised companies on corporate restructuring, divestitures, raising funds, insurance, and collaborating on joint ventures.

Heavily involved in biotech and nutraceuticals, Richard DiVenuto helped these companies grow from a start-up, to a valuation of over $1.5 billion in combined valuations. Further adding value to biotech companies, Mr. DiVenuto has assisted these companies in implementing corporate stock option plans and 401-k&#39;s, developing strategies, following through with acquisitions (strategic partnerships), and providing insights on structuring entities optimally for tax purposes. His management, team building, and vision have proven instrumental in growing the research and development capabilities of innovative biotech companies, often fast tracking the introduction of innovative treatments in the market.

Richard DiVenuto is an alumnus of Iona College in New Rochelle, New York, where he studied finance. In his free time, he enjoys boating and working out.
</description>
      <language>en-us</language>
      <pubDate>2019-12-24 06:18:20 UTC</pubDate>
      <lastBuildDate>2022-02-03 04:04:58 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Project Edge- ULT X Speeds up Remote Computing of Large Data</title>
         <author>RichardDiVenuto</author>
         <link>https://padlet.com/RichardDiVenuto/About/wish/1626107050</link>
         <description><![CDATA[<div>An experienced consultant and advisor, Richard DiVenuto works with biotech and technology companies. Residing in Balmville, New York, with his wife and three children, Richard DiVenuto provides advice to investors who seek to invest in promising technology companies in California, Florida, and Boston, Massachusetts. One of the companies he has promoted is Vcinity Inc.</div>]]></description>
         <enclosure url="https://richarddivenuto.home.blog/2020/10/22/project-edge-ult-x-speeds-up-remote-computing-of-large-data/" />
         <pubDate>2021-06-26 02:49:38 UTC</pubDate>
         <guid>https://padlet.com/RichardDiVenuto/About/wish/1626107050</guid>
      </item>
      <item>
         <title>Downsides of Autologous CAR T Cells</title>
         <author></author>
         <link>https://padlet.com/RichardDiVenuto/About/wish/1640063780</link>
         <description><![CDATA[<div>An accomplished entrepreneur-advisor and innovative tactician who has worked extensively in Florida, New York, California, and Boston in Massachusetts, <a href="https://www.slideshare.net/RichardDiVenuto"><strong>Richard DiVenuto</strong></a> serves as an advisor to two Biotechnology companies. In this role, Richard DiVenuto implements and monitors corporate stock options for the board of directors and employees. His current area of focus also includes stem cell therapies for cancers and autoimmune disorders.</div>]]></description>
         <enclosure url="https://richarddivenuto.blogspot.com/2021/01/downsides-of-autologous-car-t-cells.html" />
         <pubDate>2021-07-07 07:55:55 UTC</pubDate>
         <guid>https://padlet.com/RichardDiVenuto/About/wish/1640063780</guid>
      </item>
      <item>
         <title>How SARS-CoV-2 Progresses in the Lungs</title>
         <author>RichardDiVenuto</author>
         <link>https://padlet.com/RichardDiVenuto/About/wish/2026737892</link>
         <description><![CDATA[<div>A New York technology consultant who has worked with biotechnology and information technology firms spamming California, Florida, and Boston, Massachusetts, Richard DiVenuto has a strong interest in cell therapy to address complex diseases. A current area of focus for Richard DiVenuto centers on understanding COVID-19, which has impacted Americans across the country.</div>]]></description>
         <enclosure url="https://richarddivenuto.home.blog/2020/09/29/how-sars-cov-2-progresses-in-the-lungs/" />
         <pubDate>2022-02-03 04:04:58 UTC</pubDate>
         <guid>https://padlet.com/RichardDiVenuto/About/wish/2026737892</guid>
      </item>
   </channel>
</rss>
